Table 2:
Treatment characteristics
| Characteristics | No. (%) |
|---|---|
| Pre-RT Neck Dissection | |
| Yes | 44 (17) |
| No | 213 (82) |
| Type of pre-RT Neck Dissection * | |
| Selective | 18 (41) |
| Modified | 17 (39) |
| Radical | 6 (13) |
| Not Specified | 3 (87) |
| IMRT Technique | |
| Split | 180 (69) |
| WF-IMRT | 80 (31) |
| Mucosal site targeted | |
| Entire Pharyngolaryngeal Mucosa | 78 (30) |
| Naso-, Oro-pharynx | 167 (64) |
| Mucosa Not Targeted | 11 (4) |
| Not Specified | 4 (2) |
| Overall Radiation treatment time (IQR, days) | 41 (39–43) |
| Induction chemotherapy | |
| Yes | 63 (24) |
| No | 197 (76) |
| Type of Induction chemotherapy * | |
| Taxane+ Platinum Based | 47 (75) |
| Platinum+ Cetuximab Based | 15 (24) |
| Not specified | 1 (<1) |
| Concurrent chemotherapy * | |
| Yes | 65 (25) |
| No | 195 (75) |
| Type of Concurrent chemotherapy * | |
| Taxane+ Platinum Based | 2 (3) |
| Cisplatin | 29(45) |
| Carboplatin | 18(28) |
| Cetuximab | 12 (18) |
| Not Specified | 4 (6) |
Abbreviations
RT: Radiation Therapy; IMRT: Intensity Modulated Radiation Therapy; WF-IMRT: Whole field- Intensity Modulated Radiation Therapy; IQR: Interquartile Range.
*
percentages of those that received the specified treatment